Results 1 to 10 of about 303,751 (297)

The stratification of cirrhosis [PDF]

open access: yesHepatology Research, 2020
Cirrhosis is traditionally seen as an irreversible stage of chronic liver disease although its clinical course may last several years. Overall, the clinical management of patients with cirrhosis is based on the observation of clinical events mostly related to complications of portal hypertension.
Maurice, J, Pinzani, M
openaire   +4 more sources

Computed Tomography Images of Spontaneous Portosystemic Shunt in Liver Cirrhosis

open access: yesCanadian Journal of Gastroenterology and Hepatology, 2022
Spontaneous portosystemic shunt (SPSS) refers to collateral vessels that communicate between the portal vein system and systemic circulation. SPSS mainly includes esophageal varices, gastric varices, left gastric vein, recanalized paraumbilical vein ...
Fangfang Yi   +7 more
doaj   +1 more source

No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis

open access: yesClinical and Applied Thrombosis/Hemostasis, 2021
Portal venous system thrombosis (PVST), a common complication of liver cirrhosis, is closely associated with thrombophilia. To explore the association of homocysteine (Hcy), anticardiolipin antibody (aCL), and anti-β2 glycoprotein I antibody (aβ 2 GPI ...
Le Wang   +8 more
doaj   +1 more source

CO2 or air cholangiography reduces the risk of post-ERCP cholangitis in patients with Bismuth type IV hilar biliary obstruction

open access: yesBMC Gastroenterology, 2020
Background Endoscopic biliary stenting by endoscopic retrograde cholangiopancreatography (ERCP) is the most common form of palliation for malignant hilar obstruction. However, ERCP in such cases is associated with a risk of cholangitis.
Wen-hui Zhang   +7 more
doaj   +1 more source

Anticoagulation in cirrhosis [PDF]

open access: yesLiver International, 2012
The Authors review and comment a recent publication by Senzolo et al.
VILLA, Erica, N. De Maria
openaire   +4 more sources

Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Hereditary hemochromatosis (HH) is widely recognized and clinical manifestations of hemochromatosis-related (HFE-related) HH is well studied in European populations.
Liyan Wu   +17 more
doaj   +1 more source

Association of C-type lectin-like receptor 2 and galectin-1 with portal vein system thrombosis in HBV-related liver cirrhosis

open access: yesFrontiers in Medicine, 2023
Background and aimsHepatitis B virus (HBV) infection is the most common cause of liver cirrhosis. Portal venous system thrombosis (PVST) is a major complication of liver cirrhosis.
Yiyan Zhang   +12 more
doaj   +1 more source

Infections in Cirrhosis [PDF]

open access: yesCurrent Treatment Options in Gastroenterology, 2019
Patients with cirrhosis are at high risk of developing serious infections. Bacterial infections remain the most common cause of morbidity and mortality in these patients. This review is focused on the prevalence of infections in those with cirrhosis, including multidrug-resistant (MDR) pathogens, pathogenesis of infection-related acute-on-chronic liver
K. Rajender Reddy, Sirina Ekpanyapong
openaire   +2 more sources

Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis

open access: yesOrphanet Journal of Rare Diseases, 2022
Backgrounds Hereditary hemochromatosis (HH) is mainly caused by homozygous p.C282Y mutations in HFE in the Caucasians. We recently reported non-HFE mutations constitute the major cause of HH in Chinese.
Wei Zhang   +17 more
doaj   +1 more source

Hyponatraemia and cirrhosis [PDF]

open access: yesGastroenterology Report, 2014
Hyponatraemia is a common complication of advanced cirrhosis related to an impairment in the renal capacity for eliminating solute-free water, causing a retention of water that is disproportionate to the retention of sodium, thus leading to a reduction in serum sodium concentration and hypo-osmolality.
Andrés Cárdenas, Robert J. Gianotti
openaire   +3 more sources

Home - About - Disclaimer - Privacy